Clinical Trial

The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease

Recruiting
View on ClinicalTrials.gov →
Summary
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
Trial Details
NCT Number NCT06548256
Lead Sponsor Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions Clostridium Butyricum Miyairi, Parkinson Disease
Enrollment 400 participants
Start Date 2023-10-31
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-12